Xiangqi Li Selected Research

Xiangqi Li Research Topics

Disease

12	Pain (Aches) 10/2012 - 08/2002
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
9	Neoplasms (Cancer) 12/2020 - 02/2015
8	Hyperalgesia 10/2012 - 10/2002
3	Inflammation (Inflammations) 09/2012 - 06/2006
3	Wounds and Injuries (Trauma) 12/2010 - 10/2007
3	Surgical Wound 12/2010 - 06/2006
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2015
2	Placenta Previa 01/2022 - 01/2022
2	Macular Degeneration (Age-Related Maculopathy) 11/2020 - 01/2020
2	Carcinogenesis 01/2020 - 02/2019
2	Edema (Dropsy) 08/2008 - 06/2006
2	Neuralgia (Stump Neuralgia) 08/2008 - 03/2003
1	Ankylosis 01/2022
1	Vascular Calcification 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Insulin Resistance 01/2021
1	Cytokine Release Syndrome 01/2021
1	Triple Negative Breast Neoplasms 12/2020
1	Infections 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Obesity 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Genomic Instability 05/2015
1	Testicular Neoplasms (Testicular Cancer) 05/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014
1	Lymphatic Metastasis 01/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
6	CytokinesIBA 06/2021 - 06/2006
5	Formaldehyde (Formol)FDA Link 02/2010 - 04/2004
4	Morphine (MS Contin)FDA LinkGeneric 10/2012 - 05/2005
4	Opioid Analgesics (Opioids)IBA 10/2012 - 10/2002
4	InterleukinsIBA 09/2012 - 12/2010
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
3	Pharmaceutical PreparationsIBA 11/2020 - 02/2019
3	Verteporfin (Visudyne)FDA Link 11/2020 - 01/2020
2	AntigensIBA 11/2020 - 05/2015
2	Photosensitizing Agents (Photosensitizers)IBA 11/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019 - 01/2018
2	Freund's AdjuvantIBA 09/2012 - 05/2005
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2011 - 12/2010
2	Substance PIBA 07/2011 - 10/2002
2	ChemokinesIBA 12/2010 - 12/2010
2	Interleukin-1 (Interleukin 1)IBA 12/2010 - 12/2010
2	Complement System Proteins (Complement)IBA 02/2010 - 06/2006
2	Nerve Growth Factor (NGF)IBA 08/2008 - 11/2004
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 03/2003 - 08/2002
2	Glutamic Acid (Glutamate)FDA Link 10/2002 - 08/2002
1	CollagenIBA 01/2022
1	AndrogensIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022
1	OsteocalcinIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	ResistinIBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2021
1	xihuangIBA 12/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2020
1	Phenobarbital (Luminal)FDA Link 11/2020
1	Estrogen ReceptorsIBA 11/2020
1	Epidermal Growth Factor (EGF)IBA 11/2020
1	Caspase 9IBA 10/2020
1	Coffee FDA Link 01/2020
1	TeaIBA 01/2020
1	TEA Domain Transcription FactorsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	yangheIBA 02/2019
1	Apoptosis Regulatory ProteinsIBA 02/2019
1	9,10-Dimethyl-1,2-benzanthraceneIBA 02/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018
1	AldosteroneIBA 01/2018
1	AdipokinesIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Insulin-Like PeptidesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	1- (N- (2- methoxybenzyl)acetylamino)- 3- (1H- indol- 3- yl)- 2- (N- (2- (4- (piperidin- 1- yl)piperidin- 1- yl)acetyl)amino)propane (Lanepitant)IBA 10/2012
1	Opioid Peptides (Opioid Peptide)IBA 09/2012
1	CarrageenanIBA 09/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2012
1	SurvivinIBA 01/2012
1	Vascular Endothelial Growth Factor CIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2011

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2015
2	Cesarean Section (Caesarean Section) 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 11/2020 - 01/2018
2	Analgesia 02/2010 - 10/2007
2	Spinal Injections 10/2002 - 08/2002
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Immunotherapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2020
1	Chemoprevention 02/2019